Rebecca H Ritchie Selected Research

Angiotensin II

1/2019	Angiotensin II Type I Receptor Antagonism Attenuates Nicotine-Induced Cardiac Remodeling, Dysfunction, and Aggravation of Myocardial Ischemia-Reperfusion Injury in Rats.
5/2011	Determination of the exact molecular requirements for type 1 angiotensin receptor epidermal growth factor receptor transactivation and cardiomyocyte hypertrophy.
9/2004	Activation of IP prostanoid receptors prevents cardiomyocyte hypertrophy via cAMP-dependent signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rebecca H Ritchie Research Topics

Disease

19	Fibrosis (Cirrhosis) 02/2024 - 06/2010
18	Diabetic Cardiomyopathies 03/2024 - 06/2010
17	Hypertrophy 01/2021 - 10/2002
15	Inflammation (Inflammations) 02/2024 - 01/2017
13	Heart Failure 04/2023 - 06/2014
12	Cardiomyopathies (Cardiomyopathy) 01/2023 - 02/2010
11	Cardiomegaly (Heart Hypertrophy) 02/2024 - 09/2003
11	Insulin Resistance 02/2020 - 01/2006
8	Type 2 Diabetes Mellitus (MODY) 04/2023 - 02/2012
7	Hypertension (High Blood Pressure) 05/2023 - 07/2010
7	Left Ventricular Dysfunction 01/2023 - 06/2014
7	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2017
7	Hyperglycemia 01/2020 - 06/2011
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 04/2008
6	Reperfusion Injury 01/2019 - 04/2015
5	Heart Diseases (Heart Disease) 01/2017 - 04/2003
4	Body Weight (Weight, Body) 01/2021 - 06/2015
4	Ischemia 01/2021 - 01/2003
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 02/2012
3	Glucose Intolerance 01/2021 - 06/2011
3	Diabetes Complications 01/2021 - 01/2017
3	Diabetes Mellitus 01/2020 - 05/2015
3	Myocardial Infarction 01/2020 - 01/2018
3	Myocardial Ischemia (Ischemic Heart Diseases) 01/2019 - 09/2006
2	Atherosclerosis 12/2022 - 01/2021
2	Cardiac Arrhythmias (Arrythmia) 01/2021 - 01/2021
2	Peripheral Arterial Disease 01/2021 - 01/2021
2	Stroke (Strokes) 01/2019 - 01/2018
2	Diabetic Nephropathies (Diabetic Nephropathy) 07/2017 - 02/2012
2	Myocardial Reperfusion Injury 01/2017 - 01/2013

Drug/Important Bio-Agent (IBA)

14	Streptozocin (Streptozotocin)FDA Link 06/2023 - 04/2008
10	Glucose (Dextrose)FDA LinkGeneric 04/2023 - 01/2003
10	Superoxides (Superoxide)IBA 01/2021 - 10/2006
8	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2023 - 10/2002
8	Insulin (Novolin)FDA Link 04/2023 - 02/2010
7	Proteins (Proteins, Gene)FDA Link 02/2024 - 06/2010
7	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 02/2010
7	AntioxidantsIBA 07/2017 - 01/2007
6	Blood Glucose (Blood Sugar)IBA 10/2022 - 06/2015
6	FructoseIBA 12/2016 - 05/2010
5	CollagenIBA 02/2024 - 06/2015
5	nitroxylIBA 01/2020 - 01/2012
5	NADPH Oxidases (NAD(P)H oxidase)IBA 07/2017 - 01/2012
4	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 09/2023 - 01/2017
4	RelaxinIBA 06/2023 - 01/2018
3	CalciumIBA 02/2024 - 01/2017
3	ProstaglandinsIBA 05/2023 - 09/2004
3	Citric Acid (Citrate)FDA LinkGeneric 01/2023 - 04/2008
3	MicroRNAs (MicroRNA)IBA 10/2022 - 06/2014
3	CytokinesIBA 01/2021 - 07/2017
3	Peptides (Polypeptides)IBA 01/2019 - 01/2003
3	Angiotensin IIIBA 01/2019 - 09/2004
3	Atrial Natriuretic Factor (ANF)IBA 10/2015 - 02/2003
3	coenzyme Q10 (CoQ10)IBA 10/2015 - 02/2012
3	Cyclic GMPIBA 09/2003 - 10/2002
2	Annexin A1IBA 02/2024 - 01/2019
2	GTP-Binding Proteins (G-Protein)IBA 09/2023 - 05/2011
2	BuffersIBA 01/2023 - 07/2013
2	salicylhydroxamic acid (SHAM)IBA 01/2023 - 01/2020
2	Connective Tissue Growth FactorIBA 01/2023 - 10/2015
2	SugarsIBA 01/2022 - 05/2010
2	ResveratrolIBA 01/2021 - 01/2007
2	InflammasomesIBA 01/2021 - 01/2018
2	NLR ProteinsIBA 01/2021 - 01/2018
2	Nicotine FDA Link 01/2021 - 01/2019
2	HexosaminesIBA 01/2020 - 01/2017
2	EnzymesIBA 01/2020 - 12/2016
2	Thrombin FDA Link 01/2019 - 10/2014
2	Metalloproteases (Metalloproteinases)IBA 01/2018 - 05/2011
2	Ramipril (Altace)FDA LinkGeneric 07/2017 - 07/2013
2	tempolIBA 07/2017 - 10/2006
2	Phosphatidylinositols (Phosphatidylinositol)IBA 06/2017 - 10/2015
2	LipidsIBA 01/2017 - 06/2015
2	Dietary SugarsIBA 12/2016 - 02/2010
2	UbiquinoneIBA 10/2015 - 02/2012
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 07/2013 - 09/2003
2	Soluble Guanylyl CyclaseIBA 01/2012 - 01/2012
2	LigandsIBA 01/2012 - 05/2011
2	Messenger RNA (mRNA)IBA 09/2004 - 02/2003
2	Phenylalanine (L-Phenylalanine)FDA Link 09/2004 - 02/2003
2	BradykininIBA 09/2003 - 10/2002
2	GuanosineIBA 09/2003 - 10/2002
1	GlycogenIBA 03/2024
1	GlucocorticoidsIBA 02/2024
1	ElastinIBA 02/2024
1	Interleukin-6 (Interleukin 6)IBA 06/2023
1	Bile Acids and Salts (Bile Acids)IBA 06/2023
1	Peptide Receptors (Peptide Receptor)IBA 04/2023
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 04/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 04/2023
1	Endothelin Receptors (Endothelin Receptor)IBA 04/2023
1	Angiotensin II Type 1 Receptor BlockersIBA 04/2023
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 04/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2023
1	Adrenergic Receptors (Adrenergic Receptor)IBA 04/2023
1	Angiotensin Receptor AntagonistsIBA 04/2023
1	omega-Chloroacetophenone (Mace)IBA 04/2023

Therapy/Procedure

21	Therapeutics 03/2024 - 12/2009
8	Drug Therapy (Chemotherapy) 09/2023 - 09/2009
2	Injections 01/2023 - 10/2022